One of the major issues of the present work lies in the identification, for the first time, that IP3R3, by regulating the Ca2+ homeostasis in an anti-oscillating profile, impact the migratory capacities of breast cancer cells. The gene discussed is ITPR3; the disease is breast carcinoma.